Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,206 shares at $421.77 ($3.0M) on 2024-02-21, disclosed to the SEC on 2024-02-23.
Scheduled sale ($3.0M) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $421.77 | 3,603 | $1.5M | 50.0% |
| 2 | $421.77 | 3,603 | $1.5M | 50.0% |
| Total | $421.77 avg | 7,206 | $3.0M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |
| VRTX | SELL | 2023-12-15 | $3.4M | — | Filing → |